Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-26

FDA Approved: BOSENTAN — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved Sun Pharmaceutical Industries' original application for Bosentan, enabling a generic version of the endothelin receptor antagonist. Bosentan is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bosentan (Bosentan)

Snippet

ORIG AP for BOSENTAN (BOSENTAN)